Jaguar Health Files S-3 Registration Statement and Provides Clinical Trial Update

Article summary

Jaguar Health has filed an SEC Form S-3 to register up to $75 million in securities and announced the completion of enrollment for its pivotal crofelemer trial in microvillus inclusion disease (MVID).